These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3078052)

  • 1. [Leprechaunism].
    Nagata N; Matsuda I
    Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):865-9. PubMed ID: 3078052
    [No Abstract]   [Full Text] [Related]  

  • 2. [Donohue's syndrome (Leprechaunism)].
    Imamura T; Kobayashi M
    Nihon Rinsho; 1994 Oct; 52(10):2643-7. PubMed ID: 7983792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leprechaunism and related syndromes with primary insulin resistance: heterogeneity of molecular defects.
    Rechler MM
    Prog Clin Biol Res; 1982; 97():245-81. PubMed ID: 6760206
    [No Abstract]   [Full Text] [Related]  

  • 4. [Leprechaunism (Donohue syndrome)].
    Morooka K
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():801-3. PubMed ID: 12387087
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecular analysis of the insulin receptor gene for prenatal diagnosis of leprechaunism in two families.
    Desbois-Mouthon C; Girodon E; Ghanem N; Caron M; Pennerath A; Conteville P; Magre J; Besmond C; Goossens M; Capeau J; Amselem S
    Prenat Diagn; 1997 Jul; 17(7):657-63. PubMed ID: 9249867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meg1/Grb10 overexpression causes postnatal growth retardation and insulin resistance via negative modulation of the IGF1R and IR cascades.
    Shiura H; Miyoshi N; Konishi A; Wakisaka-Saito N; Suzuki R; Muguruma K; Kohda T; Wakana S; Yokoyama M; Ishino F; Kaneko-Ishino T
    Biochem Biophys Res Commun; 2005 Apr; 329(3):909-16. PubMed ID: 15752742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Leprechaunism(Donohue syndrome)].
    Morooka K
    Ryoikibetsu Shokogun Shirizu; 2000; (30 Pt 5):207-8. PubMed ID: 11057198
    [No Abstract]   [Full Text] [Related]  

  • 8. [Biological and clinical analyses of the mechanism of growth retardation and the effect of recombinant human insulin-like growth factor-1 (rhIGF-1) treatment on glucose metabolism and growth in leprechaunism with severe insulin resistant diabetes].
    Kato M
    Hokkaido Igaku Zasshi; 1998 Nov; 73(6):613-25. PubMed ID: 10036618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Physiologic and physiopathologic implications of insulin-receptor interaction (III)].
    Durán García S; González Mateo MC
    Med Clin (Barc); 1984 May; 82(17):771-6. PubMed ID: 6429461
    [No Abstract]   [Full Text] [Related]  

  • 10. Multiple molecular mechanisms of insulin receptor dysfunction in a patient with Donohue syndrome.
    Whitehead JP; Soos MA; Jackson R; Tasic V; Kocova M; O'Rahilly S
    Diabetes; 1998 Aug; 47(8):1362-4. PubMed ID: 9703342
    [No Abstract]   [Full Text] [Related]  

  • 11. [Leprechaunism: an inherited insulin resistance syndrome caused by the defect of insulin receptor].
    Jiang L; Liu C; Wang WQ; Ye L; Zhu N; Zhou WW; Su TW; Li XY; Ning G
    Zhonghua Nei Ke Za Zhi; 2006 Sep; 45(9):730-3. PubMed ID: 17166446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the insulin receptor gene and insulin binding in families with severe insulin resistance.
    Elsas LJ; Longo N; Fotion TR; Langley S
    Trans Assoc Am Physicians; 1988; 101():137-48. PubMed ID: 2908370
    [No Abstract]   [Full Text] [Related]  

  • 13. [Leprechaunism (Donohue syndrome)].
    Fujieda K
    Nihon Rinsho; 2006 Sep; Suppl 3():94-9. PubMed ID: 17022508
    [No Abstract]   [Full Text] [Related]  

  • 14. Proteinuria, the podocyte, and insulin resistance.
    Fornoni A
    N Engl J Med; 2010 Nov; 363(21):2068-9. PubMed ID: 21083394
    [No Abstract]   [Full Text] [Related]  

  • 15. [Insulin and its cellular receptors in changes in glucose metabolism].
    de Pabio F; Roth J; Hedo JA
    Rev Clin Esp; 1981 Aug 15-31; 162(3-4):79-88. PubMed ID: 7031791
    [No Abstract]   [Full Text] [Related]  

  • 16. [Mechanisms of insulin resistance].
    Le Marchand-Brustel Y; Tanti JF; Rochet N; Grémeaux T; Van Obberghen E
    Journ Annu Diabetol Hotel Dieu; 1989; ():175-84. PubMed ID: 2668611
    [No Abstract]   [Full Text] [Related]  

  • 17. Pathophysiology of insulin resistance.
    Sesti G
    Best Pract Res Clin Endocrinol Metab; 2006 Dec; 20(4):665-79. PubMed ID: 17161338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extreme insulin resistance in association with abnormally high binding affinity of insulin receptors from a patient with leprechaunism: evidence for a defect intrinsic to the receptor.
    Taylor SI; Hedo JA; Underhill LH; Kasuga M; Elders MJ; Roth J
    J Clin Endocrinol Metab; 1982 Dec; 55(6):1108-13. PubMed ID: 7130338
    [No Abstract]   [Full Text] [Related]  

  • 19. Defects of insulin and IGF-1 action at receptor and postreceptor level in a patient with type A syndrome of insulin resistance.
    Knebel B; Kellner S; Kotzka J; Siemeister G; Dreyer M; Streicher R; Schiller M; Rüdiger HW; Seemanova E; Krone W; Müller-Wieland D
    Biochem Biophys Res Commun; 1997 May; 234(3):626-30. PubMed ID: 9175764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leprechaunism/Donohue syndrome/insulin receptor gene mutations: a syndrome delineation story from clinicopathological description to molecular understanding.
    Kosztolányi G
    Eur J Pediatr; 1997 Apr; 156(4):253-5. PubMed ID: 9128805
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.